Hamilton Thorne Ltd.
HTL
Classifica tra le azioni
#16956
Hamilton Thorne Ltd. is a leading enterprise focused on the development,... Hamilton Thorne Ltd. is a leading enterprise focused on the development, manufacturing, and global distribution of specialized instrumentation, laboratory equipment, consumables, software, and a range of services. The company's offerings are primarily directed towards the fields of assisted reproductive technologies (ART), scientific research, and cell biology. Their product line includes sophisticated laser and imaging systems designed for biological studies, custom-built workstations, incubators, and essential equipment for IVF laboratories. They also produce critical medical devices for reproductive medicine, such as ovum pickup needles and catheters, and provide comprehensive in-vitro diagnostic (IVD) systems, from initial research and design to sales, installation, and ongoing servicing. Environmental control solutions like the Cell-Tek Microscope Chamber, which meticulously manages temperature, airflow, and humidity, are also part of their extensive catalog, alongside laminar flow workstations. Furthermore, Hamilton Thorne pioneers software innovations, including AI-powered CASA (Computer-Assisted Sperm Analysis) for image analysis. The company's service array covers thorough laboratory testing, notably endotoxin analysis and specialized sperm assays (like the Sperm Motility Index and Sperm Penetration), as well as the provision of fresh and cryopreserved mouse embryos, coupled with technician training and proficiency testing programs. Marketed under respected brand names such as Hamilton Thorne, Gynemed, Planer, Tek-Event, IVFtech, MICROPTIC, Gynétics, and Embryotech, their products and services reach a diverse global customer base—including fertility clinics, hospitals, pharmaceutical and biotechnology companies, academic institutions, and various commercial research entities—via a direct sales presence in countries like the United States, Germany, France, Australia, Denmark, Belgium, Spain, and the United Kingdom, complemented by an extensive distributor network covering around 100 nations. Hamilton Thorne Ltd. maintains its headquarters in Beverly, Massachusetts.
Prezzo delle azioni
$1.64
Ultima sincronizzazione: 2024-12-02
Capitalizzazione di mercato
$253.46M
Variazione (1 giorno)
2.87%
Variazione (1 anno)
3.40%
Paese
US
Scambia Hamilton Thorne Ltd. (HTL)
Categoria
Healthcare
Ricavi di Hamilton Thorne Ltd. (HTL)
Ricavi nel Sep 2024 TTM: $76.72M
Secondo gli ultimi rapporti finanziari di Hamilton Thorne Ltd., i ricavi attuali dell'azienda (TTM) sono pari a $76.72M. Nel 2022, l'azienda ha registrato ricavi di $55.87M un aumento rispetto a i ricavi dell'anno 2021, che erano pari a $52.35M. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per Hamilton Thorne Ltd. da 2008 a 2026
Ricavi alla fine di ogni anno
| Anno | Ricavi | Cambia |
|---|---|---|
| 2026 (TTM) | $76.72M | 14.13% |
| 2023 | $67.23M | 20.32% |
| 2022 | $55.87M | 6.72% |
| 2021 | $52.35M | 31.61% |
| 2020 | $39.78M | 12.50% |
| 2019 | $35.36M | 21.03% |
| 2018 | $29.21M | 32.06% |
| 2017 | $22.12M | 110.38% |
| 2016 | $10.51M | 16.39% |
| 2015 | $9.03M | 3.75% |
| 2014 | $8.71M | 16.45% |
| 2013 | $7.48M | 18.20% |
| 2012 | $6.33M | -11.64% |
| 2011 | $7.16M | 15.46% |
| 2010 | $6.20M | 29.32% |
| 2009 | $4.79M | 13,987.95% |
| 2008 | $34.03K | 0.00% |
Ricavi di aziende simili o concorrenti
| Azienda | Ricavi | Differenza nei ricavi | Il paese |
|---|---|---|---|
| $11.03B | 14,282.21% |
US
|
|
| $34.74B | 45,175.54% |
FR
|
|
| - | - |
JP
|
|
| $20.84B | 27,061.50% |
US
|
|
| - | - |
CH
|
